Music: 12 tracks, shuffled — tap to play.
Rethinking addiction treatment, recovery, and the revolving door of American healthcare
I am writing this not just in my own voice, but in the voice of all the sufferers.
Dedicated to my daughter, Lydia May McLean.
With special consideration to my mother for her support and love.
Listen to the report
Dystopian America: Still Hopeful — an animated image from ChatGPT.
The problem is the life you have to go back to.
Imagine spending weeks fighting your way through withdrawal, enduring physical pain, psychological distress, and the difficult process of getting drugs out of your system.
You make it through.
You have completed treatment. You are discharged. You are told to move forward, stay clean, and rebuild your life.
But where do you go?
Perhaps you return to the same tent, the same street, the same people, the same poverty, the same isolation, and the same circumstances you were living in before treatment.
You have no stable housing, no reliable income, no transportation, and perhaps no family or support system waiting for you.
The physical withdrawal may be over, but the problems that surrounded your addiction are still there.
This is the question our addiction-treatment system needs to answer:
What exactly are we expecting people to recover into?
For too many people, treatment becomes a pause button. It interrupts substance use temporarily without necessarily changing the circumstances that make returning to it so likely.
When that person uses again, the system records a relapse.
What it rarely records is what that person was discharged back into.
The problem is the life you have to go back to.
According to the Substance Abuse and Mental Health Services Administration (SAMHSA), 2024 National Survey on Drug Use and Health:
Put simply:
52.6 million people needed treatment. Only about 20 percent of them actually received it.
That is approximately one in five people who needed treatment.
These are two different measurements: 48.4 million is the number who experienced a substance use disorder, while 52.6 million is SAMHSA's broader estimate of people classified as needing treatment.
The numbers describe an enormous national problem before we even begin examining what happens after someone receives treatment.
Detoxification can be medically important. It can help people safely manage withdrawal and begin treatment.
But detoxification alone is not a complete recovery plan.
For people with opioid use disorder, the distinction can be particularly dangerous.
The Providers Clinical Support System (PCSS) reports that up to 90 percent of people in some studies returned to opioid use within the following months after completing detoxification without ongoing medication support.
That figure applies to the specific population undergoing opioid detoxification, not to everyone with a substance use disorder.
The National Institute on Drug Abuse (NIDA) reports general relapse rates of approximately 40–60 percent for substance use disorders, comparable to 50–70 percent for hypertension and asthma.
This comparison matters.
We do not generally consider someone with hypertension a failure because their condition returns. We adjust their treatment.
We do not tell someone with asthma that they have exhausted their right to medical care because their symptoms returned.
Yet people experiencing addiction are frequently treated as though relapse represents a personal or moral failure rather than a signal that treatment needs to continue or change.
Addiction is a chronic, treatable health condition. Returning to use should trigger renewed intervention, not abandonment.
There is another part of this problem that deserves attention: the loss of tolerance.
When someone stops using opioids, their body loses some of its tolerance. Returning to a previously familiar dose can therefore cause an overdose.
Research has documented this danger.
In a 2003 study published in the British Medical Journal, Strang and colleagues followed 137 people receiving inpatient opiate detoxification.
Five died within 12 months of discharge. Three died from overdose within the first four months. All three overdose deaths occurred among people who had completed detoxification and lost their tolerance.
The study illustrates a critical danger: completing detoxification does not automatically mean someone is safe after discharge.
A larger Massachusetts study published in Addiction in 2020 by Walley and colleagues examined 30,681 people who underwent inpatient opioid detoxification.
People receiving no further treatment after detox had the highest mortality. Those receiving both medication for opioid use disorder and residential treatment had an 89 percent lower risk of death compared with those receiving no further treatment.
These findings reinforce an essential point:
The period after detoxification is not an afterthought. It is part of treatment.
Sending someone away without a sustainable plan can leave them exposed to serious risks precisely when their tolerance has decreased.
Consider the cycle:
The system treats each episode as another individual event.
But what if these events are connected?
What if we are repeatedly treating the visible symptom while leaving the underlying circumstances untouched?
Housing instability, poverty, untreated mental health conditions, trauma, unemployment, and isolation can all complicate recovery.
SAMHSA has reported that more than one-third of people experiencing homelessness have alcohol or substance misuse issues, while up to two-thirds report a lifetime history of substance use disorder.
The relationship works in both directions. Substance use can contribute to homelessness, and unstable housing can make recovery more difficult.
This is not an argument that housing alone cures addiction.
It is an argument that recovery becomes substantially harder when a person has nowhere safe to recover.
There is another problem worth examining: what happens to people who disappear from the statistics?
I call this concept Phantom Loss.
In manufacturing, phantom loss describes inventory that is supposed to exist on paper but is missing when someone actually counts it.
Now consider what happens when we apply that concept to people.
Imagine 100 people going through opioid detoxification without medication support.
Up to 90 relapse.
That leaves 10 out of 100 who do not relapse on paper.
But look closer at those 10.
Two of them overdose and die.
Two of them end up in prison.
One more is gone in the ghost odds and ends: lost, can't be found, vanished from the numbers.
That's five out of those ten.
Half of the people who supposedly didn't relapse didn't stay clean. They just disappeared from the statistic in a different way.
In manufacturing, they call that phantom loss.
Now we're talking about humans.
This is my hypothesis, not a verified statistical finding or the result of a published 100-person study.
The point is that a relapse statistic cannot, by itself, tell us what happened to everyone who stopped responding, died, entered prison, or otherwise disappeared from follow-up.
People who die after returning to opioid use do not get to answer another survey. Their deaths may appear in mortality records rather than subsequent relapse reporting.
Not showing up as relapsed is not the same as staying clean.
People who pass away after returning to use may be counted as deaths rather than as relapses. Their loss of tolerance after detoxification can make returning to a previous dose especially dangerous.
They remain counted as having received treatment, even when the treatment they received was not accompanied by the continuing support they needed.
This raises a serious research question:
Are we measuring recovery, or are we measuring the number of people who remain visible to the system?
Phantom Loss is a proposed way of thinking about that missing information. It deserves investigation, not presentation as an established statistic.
The following section represents the author's political and philosophical viewpoint, not a proven finding of the clinical research discussed above.
The sickness is not democracy itself.
Democratic institutions and public programs generally begin with a stated purpose: to serve people, protect rights, and provide assistance.
My concern is what happens when greed and secrecy enter those institutions.
Secrecy is the sickness.
The ability to work a system from the inside, gain influence quietly, hide behind bureaucracy, and gradually accumulate control is not a new discovery.
It is an old pattern.
Bureaucracy can become an incubator for that kind of control.
Small rules. Small offices. Small decisions. Each one appears insignificant on its own. Together, they can determine who receives help and who gets turned away.
Consider someone experiencing homelessness who seeks assistance but is told they cannot qualify because they do not have a permanent address, a conventional dwelling, or a document they have no realistic way of obtaining.
The program exists. The money has been announced. The assistance is advertised.
But the person who needs it is still standing outside.
In my view, this is how a system intended to serve everyone can gradually begin serving a smaller group with greater influence.
It can retain the language of public service while becoming increasingly inaccessible to the people it was created to help.
An open society must remain willing to examine its institutions, question authority, and demand transparency. Otherwise, the very systems designed to protect the public can become difficult for the public to challenge.
President John F. Kennedy addressed the danger of excessive secrecy in his April 27, 1961 speech to the American Newspaper Publishers Association:
"The very word 'secrecy' is repugnant in a free and open society."
His warning about concealment and public accountability remains relevant to discussions about institutional transparency.
Some people have connected that speech to theories about the circumstances of his assassination. Such connections remain theories and should not be presented as established historical facts.
The larger point stands without them: public institutions must be accountable to the people they claim to serve.
The following section represents the author's political and philosophical viewpoint. It is an extension of the author's concerns about institutional secrecy, corporate influence, and public accountability, not a published research finding.
The same pattern does not stop at government offices or public institutions. It extends into the digital world.
As technology continues to evolve, companies such as Facebook and its parent company, Meta, have become part of an increasingly important conversation about privacy, personal information, and control over communication.
In my view, lengthy privacy policies and terms of service have become another form of bureaucracy: a wall of fine print that ordinary people are expected to navigate before they can participate in modern society.
These documents may contain important information about how personal data is collected, processed, shared, and used. But the sheer complexity and length of these agreements can make meaningful understanding and informed consent difficult for the average person.
This creates an imbalance.
People depend on digital platforms to communicate, connect, work, and participate in everyday life. Meanwhile, large corporate entities hold considerable power over the systems through which those activities take place.
My concern is that corporate interests can hide behind complicated policies and legal language while maintaining control over people's information, their communications, and their access to digital services.
The question is not simply whether someone clicked an agreement or checked a box.
The question is whether that person genuinely understands what they are agreeing to, what happens to their information, and how much control they actually retain.
When privacy policies become so complicated that ordinary people cannot realistically understand them, transparency becomes little more than a formality.
The same secrecy I have described in political and public institutions can exist in the corporate digital environment. The setting changes, but the imbalance of power remains.
At a shelter door, bureaucracy can determine whether someone receives assistance. At a government office, it can determine whether someone qualifies for a program. Online, corporate policies and platform rules can determine how people's information is handled and what access they retain.
In each situation, the people affected are expected to navigate systems that may be far more complicated than they have the time, resources, or knowledge to challenge.
I believe privacy should not be treated as a privilege reserved for people who can understand complicated legal documents.
Technology should serve people, not make people increasingly dependent on systems they cannot meaningfully question or control.
Progress should bring greater transparency and accountability, not create another layer of bureaucracy behind which powerful organizations can hide.
Another barrier is the expectation that someone must already be clean before they can receive meaningful help.
That creates a contradiction.
If someone needs treatment because they are actively struggling with addiction, why should their active struggle automatically become a reason to close the door?
There is an important legal distinction here.
The Americans with Disabilities Act (ADA) does not generally protect individuals from discrimination based on current illegal drug use. However, it does protect qualifying individuals in recovery and those participating in supervised rehabilitation who are no longer engaging in illegal drug use.
The law also contains specific protections concerning access to healthcare and drug rehabilitation services. Current illegal drug use is not, by itself, a lawful reason to deny otherwise entitled health or rehabilitation services.
The precise rules depend on the service and circumstances.
The broader issue is that refusing meaningful assistance to someone because they are still struggling can shut the door at exactly the moment they need it most.
It starts as a choice. It does not stay one.
Addiction may begin with a voluntary decision to use a substance. But deep addiction is not simply a matter of continuing to make an ordinary choice.
Repeated substance exposure can change brain systems involved in reward, stress, motivation, and self-control. Compulsive use can become profoundly difficult to control.
Treating every person with addiction as though they simply need to make a better decision ignores the condition we are supposed to be treating.
The following section represents the author's viewpoint, not a published research finding.
Scapegoating means unfairly blaming one person for problems they did not cause.
The word comes from an old ritual, where a community placed its wrongdoing onto a goat and sent it into the wilderness to carry the blame away. The idea stuck because the pattern did. Groups still hand their hardest problems to one person and treat that person as the cause.
Therapists use the term in a similar way today. Instead of facing something hard, a group hands it to one person instead.
Scapegoating is a psychological defense. It works by pushing responsibility and wrongdoing onto someone else instead of facing it directly — so the people doing the blaming never have to sit with the discomfort of having been wrong.
Framing recovery purely around individual willpower acts as a societal shield.
It allows institutions to claim "help was offered" while ignoring structural failures like broken housing markets, inadequate safety nets, and healthcare limits.
When a person is discharged back into the same homelessness, the same poverty, and the same isolation, and then returns to use, the system calls it a personal failure. The person becomes the scapegoat for a pipeline that was never built to hold them.
That blame protects the system. It does not have to answer for the housing that was not there, the income that was not there, or the continuing care that was not there — because the individual has already been blamed.
Expecting long-term change without basic post-discharge stability creates a revolving door that blames the individual for structural gaps.
Scapegoating follows a pattern, and it shows up here in four ways:
If you recognize yourself in this pattern — being blamed for problems you did not cause — this is a useful resource on what to do about it: What to Do When Someone Is Using You as a Scapegoat (Anchor Therapy).
If treatment is supposed to produce lasting recovery, the plan must extend beyond the detoxification facility.
Several things need to become part of the process.
Stable housing should be secured before discharge whenever possible.
Not merely a referral. Not a waitlist. Not a piece of paper with a telephone number.
A safe place to live is a foundation for recovery.
People need a realistic way to obtain food, transportation, clothing, and other necessities.
Recovery does not happen in a vacuum. Financial instability can undermine even the strongest intentions.
For opioid use disorder, evidence-based medications such as buprenorphine and methadone can reduce overdose risk and support sustained treatment.
Detoxification without an ongoing treatment plan is not an adequate substitute.
Follow-up should last months, not merely days.
People need consistent contact, reassessment, and adjustments to treatment when symptoms return.
People need somewhere to belong.
They need people who expect them to return, opportunities to contribute, and environments that do not define them exclusively by their addiction.
A relapse should trigger renewed support.
It should not automatically terminate someone's access to treatment, housing assistance, or the opportunity to recover.
If we understand addiction as a chronic condition, our response should reflect that understanding.
We cannot demand lifelong recovery while providing only temporary assistance.
The United States spends enormous attention and resources addressing substance use disorders.
But the measure of success should not simply be how many people enter detoxification, complete a program, or leave a facility.
We should also ask:
These questions matter because people are not statistics.
Every number represents someone with a history, a family, a life, and a future that may still be possible.
The person who returns to substance use is not automatically a failed treatment.
Sometimes the treatment was incomplete.
Sometimes the circumstances were impossible.
Sometimes the person was discharged into the very conditions they were trying to escape.
And sometimes the system simply stopped following them.
Recovery should mean more than temporarily removing a substance from someone's life.
It should mean helping someone build a life in which returning to that substance is no longer the only available escape from their circumstances.
It should mean a home, stability, healthcare, meaningful work, human connection, and the opportunity to participate in society without constantly being reminded of their past.
It should mean that someone can struggle without losing their right to help.
We cannot keep measuring success by the number of people who pass through treatment facilities while ignoring what happens when they walk back outside.
We cannot keep calling it a revolving door without examining why the door keeps turning.
And we cannot keep asking people to rebuild their lives without giving them somewhere to begin.
The problem is the life you have to go back to.
Until we address that problem, we will continue treating the symptoms while leaving the conditions that surround them largely untouched.
People deserve more than a temporary pause.
They deserve a genuine opportunity to recover.
Author's note: The Phantom Loss concept, systemic scapegoating analysis, and political-system analysis are the author's original hypotheses and interpretations. They are not presented as established scientific findings. Any gathered estimates concerning severe substance use disorder, integrated housing support, or treatment access should be independently verified before publication.
Disclaimer: This report is advocacy and informational material informed by lived experience and published research. It is not medical, legal, or professional advice.